Travere Therapeutics (TVTX) Return on Capital Employed [ROCE] (2013 - 2026)
Travere Therapeutics' Return on Capital Employed [ROCE] was -21.78% in Q3 2026, up 0.34 percentage points from -22.13% a year earlier but down 14.08 percentage points from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Return on Capital Employed [ROCE] (2013 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Travere Therapeutics came in at -14.29%, up 51.70 percentage points from FY2024.
- Return on Capital Employed [ROCE] shows a five-year change of +20.02 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -65.98% in FY2024 (+4.22 pp), -70.21% in FY2023 (-15.30 pp), -54.91% in FY2022 (-19.80 pp) and -35.11% in FY2021 (-0.80 pp).
- Quarterly Return on Capital Employed [ROCE] has moved between -105.80% (Q3 2024) and -7.70% (Q2 2026) over five years.
- Compared with a year earlier, Return on Capital Employed [ROCE] has increased for seven straight quarters, with an average year-over-year change of +33.58 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q3 2025 (a gain of 83.68 percentage points); the worst was Q3 2024 (a drop of 46.81 percentage points).
- Per Business Quant data, TVTX's Return on Capital Employed [ROCE] in the three quarters before Q3 2026 was -7.70% (Q2 2026), -12.55% (Q1 2026) and -15.25% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Travere Therapeutics | 4.97 Bn | 4.56 Bn | 221.70 Mn | -21.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -21.78% |
| Jun 30, 2026 | -7.70% |
| Mar 31, 2026 | -12.55% |
| Dec 31, 2025 | -15.25% |
| Sep 30, 2025 | -22.13% |
| Jun 30, 2025 | -47.50% |
| Mar 31, 2025 | -58.42% |
| Dec 31, 2024 | -92.92% |
| Sep 30, 2024 | -105.80% |
| Jun 30, 2024 | -81.01% |
| Mar 31, 2024 | -77.76% |
| Dec 31, 2023 | -61.32% |
| Sep 30, 2023 | -58.99% |
| Jun 30, 2023 | -58.22% |
| Mar 31, 2023 | -56.61% |
| Dec 31, 2022 | -57.39% |
| Sep 30, 2022 | -51.13% |
| Jun 30, 2022 | -39.31% |
| Mar 31, 2022 | -32.77% |
| Dec 31, 2021 | -30.60% |
API Access
Travere Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();